Female Contraceptives Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: FE374AE9ACFEEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Female Contraceptives in Global, including the following market information:

Global Female Contraceptives Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Female Contraceptives market was valued at 18920 million in 2021 and is projected to reach US$ 22510 million by 2028, at a CAGR of 2.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Contraceptive Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Female Contraceptives include Bayer, Mayer Laboratories, Pfizer, Mylan, Teva, Merck, Johnson & Johnson, Lupin Pharmaceuticals and Female Health Company and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Female Contraceptives companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Female Contraceptives Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Female Contraceptives Market Segment Percentages, by Type, 2021 (%)

• Contraceptive Drugs
• Contraceptive Devices

Global Female Contraceptives Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Female Contraceptives Market Segment Percentages, by Application, 2021 (%)

• Personal use
• Hospital

Global Female Contraceptives Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Female Contraceptives Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Female Contraceptives revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Female Contraceptives revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer
• Mayer Laboratories
• Pfizer
• Mylan
• Teva
• Merck
• Johnson & Johnson
• Lupin Pharmaceuticals
• Female Health Company
• Fuji Latex

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Female Contraceptives Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Female Contraceptives Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL FEMALE CONTRACEPTIVES OVERALL MARKET SIZE

2.1 Global Female Contraceptives Market Size: 2021 VS 2028
2.2 Global Female Contraceptives Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Female Contraceptives Players in Global Market
3.2 Top Global Female Contraceptives Companies Ranked by Revenue
3.3 Global Female Contraceptives Revenue by Companies
3.4 Top 3 and Top 5 Female Contraceptives Companies in Global Market, by Revenue in 2021
3.5 Global Companies Female Contraceptives Product Type
3.6 Tier 1, Tier 2 and Tier 3 Female Contraceptives Players in Global Market
  3.6.1 List of Global Tier 1 Female Contraceptives Companies
  3.6.2 List of Global Tier 2 and Tier 3 Female Contraceptives Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Female Contraceptives Market Size Markets, 2021 & 2028
  4.1.2 Contraceptive Drugs
  4.1.3 Contraceptive Devices
4.2 By Type - Global Female Contraceptives Revenue & Forecasts
  4.2.1 By Type - Global Female Contraceptives Revenue, 2017-2022
  4.2.2 By Type - Global Female Contraceptives Revenue, 2023-2028
  4.2.3 By Type - Global Female Contraceptives Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Female Contraceptives Market Size, 2021 & 2028
  5.1.2 Personal use
  5.1.3 Hospital
5.2 By Application - Global Female Contraceptives Revenue & Forecasts
  5.2.1 By Application - Global Female Contraceptives Revenue, 2017-2022
  5.2.2 By Application - Global Female Contraceptives Revenue, 2023-2028
  5.2.3 By Application - Global Female Contraceptives Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Female Contraceptives Market Size, 2021 & 2028
6.2 By Region - Global Female Contraceptives Revenue & Forecasts
  6.2.1 By Region - Global Female Contraceptives Revenue, 2017-2022
  6.2.2 By Region - Global Female Contraceptives Revenue, 2023-2028
  6.2.3 By Region - Global Female Contraceptives Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Female Contraceptives Revenue, 2017-2028
  6.3.2 US Female Contraceptives Market Size, 2017-2028
  6.3.3 Canada Female Contraceptives Market Size, 2017-2028
  6.3.4 Mexico Female Contraceptives Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Female Contraceptives Revenue, 2017-2028
  6.4.2 Germany Female Contraceptives Market Size, 2017-2028
  6.4.3 France Female Contraceptives Market Size, 2017-2028
  6.4.4 U.K. Female Contraceptives Market Size, 2017-2028
  6.4.5 Italy Female Contraceptives Market Size, 2017-2028
  6.4.6 Russia Female Contraceptives Market Size, 2017-2028
  6.4.7 Nordic Countries Female Contraceptives Market Size, 2017-2028
  6.4.8 Benelux Female Contraceptives Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Female Contraceptives Revenue, 2017-2028
  6.5.2 China Female Contraceptives Market Size, 2017-2028
  6.5.3 Japan Female Contraceptives Market Size, 2017-2028
  6.5.4 South Korea Female Contraceptives Market Size, 2017-2028
  6.5.5 Southeast Asia Female Contraceptives Market Size, 2017-2028
  6.5.6 India Female Contraceptives Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Female Contraceptives Revenue, 2017-2028
  6.6.2 Brazil Female Contraceptives Market Size, 2017-2028
  6.6.3 Argentina Female Contraceptives Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Female Contraceptives Revenue, 2017-2028
  6.7.2 Turkey Female Contraceptives Market Size, 2017-2028
  6.7.3 Israel Female Contraceptives Market Size, 2017-2028
  6.7.4 Saudi Arabia Female Contraceptives Market Size, 2017-2028
  6.7.5 UAE Female Contraceptives Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer
  7.1.1 Bayer Corporate Summary
  7.1.2 Bayer Business Overview
  7.1.3 Bayer Female Contraceptives Major Product Offerings
  7.1.4 Bayer Female Contraceptives Revenue in Global Market (2017-2022)
  7.1.5 Bayer Key News
7.2 Mayer Laboratories
  7.2.1 Mayer Laboratories Corporate Summary
  7.2.2 Mayer Laboratories Business Overview
  7.2.3 Mayer Laboratories Female Contraceptives Major Product Offerings
  7.2.4 Mayer Laboratories Female Contraceptives Revenue in Global Market (2017-2022)
  7.2.5 Mayer Laboratories Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Female Contraceptives Major Product Offerings
  7.3.4 Pfizer Female Contraceptives Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Mylan
  7.4.1 Mylan Corporate Summary
  7.4.2 Mylan Business Overview
  7.4.3 Mylan Female Contraceptives Major Product Offerings
  7.4.4 Mylan Female Contraceptives Revenue in Global Market (2017-2022)
  7.4.5 Mylan Key News
7.5 Teva
  7.5.1 Teva Corporate Summary
  7.5.2 Teva Business Overview
  7.5.3 Teva Female Contraceptives Major Product Offerings
  7.5.4 Teva Female Contraceptives Revenue in Global Market (2017-2022)
  7.5.5 Teva Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Female Contraceptives Major Product Offerings
  7.6.4 Merck Female Contraceptives Revenue in Global Market (2017-2022)
  7.6.5 Merck Key News
7.7 Johnson & Johnson
  7.7.1 Johnson & Johnson Corporate Summary
  7.7.2 Johnson & Johnson Business Overview
  7.7.3 Johnson & Johnson Female Contraceptives Major Product Offerings
  7.7.4 Johnson & Johnson Female Contraceptives Revenue in Global Market (2017-2022)
  7.7.5 Johnson & Johnson Key News
7.8 Lupin Pharmaceuticals
  7.8.1 Lupin Pharmaceuticals Corporate Summary
  7.8.2 Lupin Pharmaceuticals Business Overview
  7.8.3 Lupin Pharmaceuticals Female Contraceptives Major Product Offerings
  7.8.4 Lupin Pharmaceuticals Female Contraceptives Revenue in Global Market (2017-2022)
  7.8.5 Lupin Pharmaceuticals Key News
7.9 Female Health Company
  7.9.1 Female Health Company Corporate Summary
  7.9.2 Female Health Company Business Overview
  7.9.3 Female Health Company Female Contraceptives Major Product Offerings
  7.9.4 Female Health Company Female Contraceptives Revenue in Global Market (2017-2022)
  7.9.5 Female Health Company Key News
7.10 Fuji Latex
  7.10.1 Fuji Latex Corporate Summary
  7.10.2 Fuji Latex Business Overview
  7.10.3 Fuji Latex Female Contraceptives Major Product Offerings
  7.10.4 Fuji Latex Female Contraceptives Revenue in Global Market (2017-2022)
  7.10.5 Fuji Latex Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Female Contraceptives Market Opportunities & Trends in Global Market
Table 2. Female Contraceptives Market Drivers in Global Market
Table 3. Female Contraceptives Market Restraints in Global Market
Table 4. Key Players of Female Contraceptives in Global Market
Table 5. Top Female Contraceptives Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Female Contraceptives Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Female Contraceptives Revenue Share by Companies, 2017-2022
Table 8. Global Companies Female Contraceptives Product Type
Table 9. List of Global Tier 1 Female Contraceptives Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Female Contraceptives Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Female Contraceptives Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Female Contraceptives Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Female Contraceptives Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Female Contraceptives Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Female Contraceptives Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Female Contraceptives Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Female Contraceptives Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Female Contraceptives Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Female Contraceptives Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Female Contraceptives Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Female Contraceptives Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Female Contraceptives Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Female Contraceptives Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Female Contraceptives Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Female Contraceptives Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Female Contraceptives Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Female Contraceptives Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Female Contraceptives Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Female Contraceptives Revenue, (US$, Mn), 2023-2028
Table 30. Bayer Corporate Summary
Table 31. Bayer Female Contraceptives Product Offerings
Table 32. Bayer Female Contraceptives Revenue (US$, Mn), (2017-2022)
Table 33. Mayer Laboratories Corporate Summary
Table 34. Mayer Laboratories Female Contraceptives Product Offerings
Table 35. Mayer Laboratories Female Contraceptives Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Female Contraceptives Product Offerings
Table 38. Pfizer Female Contraceptives Revenue (US$, Mn), (2017-2022)
Table 39. Mylan Corporate Summary
Table 40. Mylan Female Contraceptives Product Offerings
Table 41. Mylan Female Contraceptives Revenue (US$, Mn), (2017-2022)
Table 42. Teva Corporate Summary
Table 43. Teva Female Contraceptives Product Offerings
Table 44. Teva Female Contraceptives Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Female Contraceptives Product Offerings
Table 47. Merck Female Contraceptives Revenue (US$, Mn), (2017-2022)
Table 48. Johnson & Johnson Corporate Summary
Table 49. Johnson & Johnson Female Contraceptives Product Offerings
Table 50. Johnson & Johnson Female Contraceptives Revenue (US$, Mn), (2017-2022)
Table 51. Lupin Pharmaceuticals Corporate Summary
Table 52. Lupin Pharmaceuticals Female Contraceptives Product Offerings
Table 53. Lupin Pharmaceuticals Female Contraceptives Revenue (US$, Mn), (2017-2022)
Table 54. Female Health Company Corporate Summary
Table 55. Female Health Company Female Contraceptives Product Offerings
Table 56. Female Health Company Female Contraceptives Revenue (US$, Mn), (2017-2022)
Table 57. Fuji Latex Corporate Summary
Table 58. Fuji Latex Female Contraceptives Product Offerings
Table 59. Fuji Latex Female Contraceptives Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Female Contraceptives Segment by Type in 2021
Figure 2. Female Contraceptives Segment by Application in 2021
Figure 3. Global Female Contraceptives Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Female Contraceptives Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Female Contraceptives Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Female Contraceptives Revenue in 2021
Figure 8. By Type - Global Female Contraceptives Revenue Market Share, 2017-2028
Figure 9. By Application - Global Female Contraceptives Revenue Market Share, 2017-2028
Figure 10. By Region - Global Female Contraceptives Revenue Market Share, 2017-2028
Figure 11. By Country - North America Female Contraceptives Revenue Market Share, 2017-2028
Figure 12. US Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Female Contraceptives Revenue Market Share, 2017-2028
Figure 16. Germany Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 17. France Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Female Contraceptives Revenue Market Share, 2017-2028
Figure 24. China Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 28. India Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Female Contraceptives Revenue Market Share, 2017-2028
Figure 30. Brazil Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Female Contraceptives Revenue Market Share, 2017-2028
Figure 33. Turkey Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Female Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer Female Contraceptives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Mayer Laboratories Female Contraceptives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Female Contraceptives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mylan Female Contraceptives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva Female Contraceptives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Female Contraceptives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Johnson & Johnson Female Contraceptives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Lupin Pharmaceuticals Female Contraceptives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Female Health Company Female Contraceptives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Fuji Latex Female Contraceptives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)